BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35916045)

  • 1. mRNA COVID-19 Vaccine-Associated Subserosal Eosinophilic Gastroenteritis: A Case Report.
    Lee JY; Lee JH
    J Korean Med Sci; 2022 Aug; 37(30):e233. PubMed ID: 35916045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
    Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
    Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic Gastroenteritis Following Covid-19 MRNA Vaccination.
    Yoshino Y; Tsuboi K
    Eur J Case Rep Intern Med; 2024; 11(3):004316. PubMed ID: 38455695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult-onset Still's Disease after BNT162b2 mRNA COVID-19 Vaccine.
    Park SY; Lee KH
    J Korean Med Sci; 2021 Dec; 36(50):e344. PubMed ID: 34962116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular tachycardia from myocarditis following COVID-19 vaccination with tozinameran (BNT162b2, Pfizer-BioNTech).
    Lin W; Yip ACL; Evangelista LKM; Wong RCC; Tan HC; Lim TW; Singh D
    Pacing Clin Electrophysiol; 2022 Sep; 45(9):1097-1100. PubMed ID: 35306680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine.
    Nomura J; Seki M; Abe S; Kobayashi T; Okitsu Y; Fukuhara N; Takahashi S; Harigae H; Kameoka J
    Hum Vaccin Immunother; 2023 Dec; 19(1):2165381. PubMed ID: 36625832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
    Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
    JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
    Kang SH; Kim MY; Cho MY; Baik SK
    J Korean Med Sci; 2022 Apr; 37(15):e116. PubMed ID: 35437965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.
    Al-Maqbali JS; Al Rasbi S; Kashoub MS; Al Hinaai AM; Farhan H; Al Rawahi B; Al Alawi AM
    Am J Case Rep; 2021 Jun; 22():e932946. PubMed ID: 34117206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colitis with Hypereosinophilia following the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine: A Case Report with a Literature Review.
    Doman T; Saito H; Tanaka Y; Hirasawa D; Endo M; Togo D; Matsuda T
    Intern Med; 2023 Mar; 62(6):865-869. PubMed ID: 36575012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review.
    Lui DTW; Lee KK; Lee CH; Lee ACH; Hung IFN; Tan KCB
    Front Public Health; 2021; 9():778964. PubMed ID: 34888290
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    Wong CKH; Lau KTK; Xiong X; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Chan EWY; Gao L; Cheng FWT; Tang SCW; Wong ICK
    PLoS Med; 2022 Jun; 19(6):e1004018. PubMed ID: 35727759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocarditis, Pulmonary Hemorrhage, and Extensive Myositis with Rhabdomyolysis 12 Days After First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine: A Case Report.
    Al-Rasbi S; Al-Maqbali JS; Al-Farsi R; Al Shukaili MA; Al-Riyami MH; Al Falahi Z; Al Farhan H; Al Alawi AM
    Am J Case Rep; 2022 Feb; 23():e934399. PubMed ID: 35173141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights.
    Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ
    Interdiscip Sci; 2021 Jun; 13(2):344-347. PubMed ID: 34021862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
    Dionne A; Sperotto F; Chamberlain S; Baker AL; Powell AJ; Prakash A; Castellanos DA; Saleeb SF; de Ferranti SD; Newburger JW; Friedman KG
    JAMA Cardiol; 2021 Dec; 6(12):1446-1450. PubMed ID: 34374740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pfizer/BioNtech BNT162b2: adverse events and insights from an Australian mass vaccination clinic for COVID-19.
    Halder A; Imamura H; Condon S; Boroughs K; Nilsson SC; Anderson T; Caterson ID
    Intern Med J; 2022 Jan; 52(1):121-124. PubMed ID: 35060290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Case With New-Onset Neuromyelitis Optica Spectrum Disorder Following COVID-19 mRNA BNT162b2 Vaccination.
    Caliskan I; Bulus E; Afsar N; Altintas A
    Neurologist; 2022 May; 27(3):147-150. PubMed ID: 35184119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report.
    Yamada M; Sada RM; Kashihara E; Okubo G; Matsushita S; Manabe A; Tagawa S; Akebo H; Miyake H; Hatta K
    J Infect Chemother; 2022 Jul; 28(7):1008-1011. PubMed ID: 35428576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New-onset retroperitoneal fibrosis following COVID-19 mRNA vaccination: Coincidental or vaccine-induced phenomenon?
    Ture HY; Kim NR; Nam EJ
    Int J Rheum Dis; 2023 Jul; 26(7):1368-1372. PubMed ID: 36814401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.